INTRODUCTION {#s1}
============

There have been substantial changes in the delivery of sexual health care in England over the past decade reflecting national guidance^[@IJSA-12-055C1]--[@IJSA-12-055C3]^ and targets^[@IJSA-12-055C4]^ focused on improving access to sexual health care. Reflecting this strategic vision, services for sexually transmitted infections (STIs) are increasingly available outside the specialist genitourinary (GU) medicine clinic setting in community settings, including through the National Chlamydia Screening Programme (NCSP).^[@IJSA-12-055C5]^ Commissioning models introduced in the early 2000s encouraged the development of more specialized sexual health provision within primary care, including 'Locally Enhanced Services' for sexual health (LESSH). Although transferable staff competencies for STI management have been developed,^[@IJSA-12-055C6]--[@IJSA-12-055C9]^ these are not universally provided in LESSH^[@IJSA-12-055C10]^ and there are variations in the structure and scope of LESSH and their effectiveness in STI control.^[@IJSA-12-055C11]^ In some areas, all LESSH regardless of setting, provide a specified locally standardized service, but in others, LESHH perform only minimal sexual health activities,^[@IJSA-12-055C12]^ such as condom distribution.

It is unclear which models of LESSH are most cost-effective for disease control, and guidance for service planners does not address how best to commission a range of GU medicine and LESSH to maximize public health gain.^[@IJSA-12-055C13]^ There is thus an urgent need for service planners and providers to understand the risk profiles and care pathways of people who seek care for suspected STIs in their locality so as to optimize the capability of services to meet individual needs, as well as public health needs.

While GU medicine clinics routinely report surveillance data on attendances, diagnoses and access,^[@IJSA-12-055C14],[@IJSA-12-055C15]^ little is known about people seeking care from community-based services.^[@IJSA-12-055C16]^ Here we report the results of a survey tool designed to supplement routinely collected clinical data, administered in GU medicine clinics and nearby general practice-based LESSH (GP-LESSH), to compare sociodemographic and behavioural characteristics and care pathways of patients attending these services in one area of England: Cornwall.

METHODS {#s2}
=======

Setting {#s2a}
-------

We undertook a comparative cross-sectional survey of attendees at GU medicine clinics and GP-LESSH in Cornwall, a largely rural area in southwest England. Data collection ran from 2 November 2009 to 24 December 2009 in GU medicine and from 10 February 2010 to 29 April 2010 in GP-LESSH. The rationale and design of this survey, together with the study materials, have previously been published.^[@IJSA-12-055C17]^

The main GU medicine clinic opened every working day, running both appointment and walk-in clinics, and had four satellite GU medicine clinics. These offered a mixture of walk-in and appointment clinics: three operated on at least a weekly basis and one fortnightly. Access to all clinics is coordinated centrally and a walk-in facility is available at one location every working day.

LESSH are provided in three types of service in Cornwall: the majority in general practices, one Brook Advisory Centre (young people\'s clinic), and a community hospital. We surveyed all three GP-LESSH services, each aimed to provide appointments to at least 10 new patients per week, as separate timed clinics rather than dispersed appointments throughout the week.

Reception staff at both settings were asked to distribute pen-and-paper questionnaires to all patients. These asked about reason(s) for attendance, whether the patient had symptoms, when they first sought care and where, experience of other services, and sexual behaviour questions.

Questionnaires were anonymous apart from the patient\'s clinic number. Respondents were asked to consent to linkage of their questionnaire to an extract of clinical data including tests done, STI diagnosis/es made, and additionally (for GP-LESSH patients), treatment(s) and/or referral. The latter were coded for appropriateness of care (Supplementary Table S3; please see <http://std.rsmjournals.com/lookup/suppl/doi:10.1177/0956462472301/-/DC1>).

Using aggregate-level data available for both GU medicine^[@IJSA-12-055C14]^ and GP-LESSHs in Cornwall (part of Cornwall\'s LESSH requirements), we compared our patient sample to the patient population with respect to gender, age, ethnicity and whether or not STI(s) were diagnosed.

Statistical analysis {#s2b}
--------------------

We calculated percentages and percentiles to describe the sample of patients, stratified by the type of service attended (GU medicine versus GP-LESSH) and gender, and used the chi-squared statistic to identify differences between these groups. Analyses were undertaken using the survey commands in Stata 10.0^[@IJSA-12-055C18]^ to take account of clustering of patients by clinic/practice. Statistical significance was considered as *P* \< 0.05 for all analyses.

Sample size calculations were not undertaken reflecting the principal aim of the parent study to develop and demonstrate an audit tool capable of gathering epidemiological data rapidly to inform service planning.^[@IJSA-12-055C17]^

Ethical approval {#s2c}
----------------

The research protocol was approved by the London Research Ethics Committee (number: 09/H0718/1).

RESULTS {#s3}
=======

Response rates {#s3a}
--------------

Altogether, 933 GU medicine patients completed the questionnaire (one-third, 319, doing so at a satellite GU medicine clinic); 111 patients completed the questionnaire in GP-LESSH. Response rates were similar: 57.4% in GU medicine overall (range: 53.4--76.1%) versus 51.1% in GP-LESSH overall (range: 37.2--62.9%), and similar proportions of respondents consented to linkage (83.1% versus 81.3%, respectively). There were no differences between patients who consented to linkage and those who did not (data not shown). GU medicine respondents were slightly younger than the whole GU medicine patient population with 50.6% aged under 25 (versus 44.5%, *P* = 0.001), while similar comparisons for GP-LESSH found no difference.

Comparison of GU medicine versus GP-LESSH patients {#s3b}
--------------------------------------------------

### Sociodemographics {#s3b1}

Similar proportions of patients in the GU medicine and GP-LESSH samples were female (57.5% versus 61.3%, respectively), and the median age of respondents was also similar (24 versus 23 years, respectively, Supplementary Table S1; please see <http://std.rsmjournals.com/lookup/suppl/doi:10.1177/0956462472301/-/DC1>). However, male GU medicine respondents were older on average than male GP-LESSH respondents (medians: 27 versus 24 years, respectively), the latter being similar in age to their female counterparts. Reflecting the local demography, nearly all respondents were of white ethnicity.

### Sexual behaviours {#s3b2}

While nearly all (94.1%) patients surveyed in both settings reported exclusively opposite-sex partner(s) in the past year (Supplementary Table S1), 10.2% of male GU medicine respondents reported same-sex partner(s), contrasting with 5.0% of men in the GP-LESSH sample. The median number of partners in the past year was two among both GU medicine and GP-LESSH patients; however, one-tenth of men attending GU medicine reported 10 or more partners in this time-frame versus none of the men attending GP-LESSH and less than 2% of all women studied. This pattern persisted when the denominator was limited to those reporting only opposite-sex partner(s) in the past year (data not shown). GU medicine respondents more often reported new partner(s) in the past year (80.8% versus 73.3%, respectively), as well as *multiple* new partners in this time frame, at least among men (55.8% versus 45.2%). While the median number of partners in the last three months was one for all gender/service groups, men in the GU medicine sample were more likely to report at least two partners in this time frame (36.4% versus 19.1%, respectively).

### Health-related factors {#s3b3}

Nearly 90% of all respondents attended for a new episode of care (Supplementary Table S1). Two-thirds (67.4%) of men in the GP-LESSH sample had never attended the service before, a higher proportion than in the GU medicine sample (46.0%).

Nine-tenths of patients in both settings reported registration with a GP, although among men attending GP-LESSH this was lower, with a quarter responding either 'no' or 'I\'m not sure' to this question. Females in both settings were more likely than males to report previous chlamydia testing (82.5% versus 65.0% of all women and men, respectively). However, there was no difference by gender or setting in the proportion reporting previous STI diagnosis/es (approximately 1 in 3 patients surveyed).

### Reasons for seeking care {#s3b4}

The two most commonly cited reasons for seeking care were the same in the two settings: having symptoms (38.4%) or not having symptoms but wanting a check-up (37.5%), accounting for three-quarters of respondents (Supplementary Table S2; please see <http://std.rsmjournals.com/lookup/suppl/doi:10.1177/0956462472301/-/DC1>). However, more GP-LESSH patients than GU medicine patients reported seeking care because they wanted an asymptomatic check-up (47.6% versus 36.3%), while a slightly larger proportion of GU medicine patients reported wanting an HIV test as their reason for attendance (7.1% versus 4.9%).

### Accessing care {#s3b5}

GU medicine patients more often reported symptoms at the time of their consultation (30.6% versus 19.6%, respectively), and among symptomatic patients, the median time between recognizing a need to seek care and first trying to do so was seven days among GU medicine patients and nine days among GP-LESSH patients (Figure [1](#IJSA-12-055F1){ref-type="fig"}). Approximately a quarter of GU medicine patients (24.4%) reported first using, or trying to use, another health-care service, which in two-thirds of cases was general practice. This finding was unchanged when patients attending satellite GU medicine clinics were excluded (data not shown). A smaller proportion of GP-LESSH patients (9.5%) reported trying to use another health-care service first, usually another GP. Once patients sought care, GU medicine respondents received care more promptly: 46.3% were seen on the day that they first sought care compared with 12.6% of GP-LESSH patients (Figure [2](#IJSA-12-055F2){ref-type="fig"}). Figure 1Distribution of time between recognizing symptoms (denominator is limited to those reporting symptoms: 30.6% of GU medicine patients \[*n* = 266\]; 19.6% of GP-LESSH patients \[*n* = 22\]) and first seeking care by setting (GU medicine clinic versus GP-LESSH) (No statistically significant gender difference in either settings). GU = genitourinary; GP-LESSH = general practice-based Locally Enhanced Services for Sexual Health Figure 2Distribution of time since first seeking care from any health-care service and being seen in the study clinic/practice by setting (GU medicine clinic versus GP-LESSH) (No statistically significant gender difference in either setting). Denominator is all patients: 933 GU medicine patients and 111 GP-LESSH patients. GU = genitourinary; GP-LESSH = general practice-based Locally Enhanced Services for Sexual Health

### Sex since recognizing a need to seek care {#s3b6}

Despite their longer care pathway, GP-LESSH respondents were equally likely as GU medicine respondents to report sex since recognizing a need to seek care (40.7% of all patients, Table [1](#IJSA-12-055TB1){ref-type="table"}). However, fewer male GU medicine respondents reported sex during this time than male GP-LESSH respondents (33.7% versus 45.0%, respectively); while among women the converse was evident (46.1% versus 33.9%, respectively). Over 80% of all respondents reporting sex while seeking care reported just one partner during this time, although more GU medicine patients reported multiple partners: 20.0% versus 7.5%, with this difference more marked for men (19.5% versus 5.6%) than women (20.3% versus 9.1%, respectively). Table 1A comparison of patients' sexual risk behaviour since recognizing a need to seek care by setting (GU medicine clinic versus GP-LESSH) and genderGenderMales and femalesMalesFemalesSetting:GU medicineGP-LESSH*P* value\*GU medicineGP-LESSH*P* value\*GU medicineGP-LESSH*P* value\**Denominator* ^†^*9331113974353668*Had sex since recognized a need to seek care41.0%38.1%0.61733.7%45.0%0.06146.1%33.9%0.854*Denominator* ^‡,§^ *:36340124****18****239****22***2+ partners since recognized a need to seek care20.0%7.5%0.06719.5%**5.6%0.022**20.3%**9.1%0.154**Any *new* partners since recognized a need to seek care44.7%33.3%\<0.00142.7%**27.8%0.091**45.7%**38.1%0.307**Median number of sex acts since recognized a need to seek care (lower, upper quartiles)4 (2, 10)4 (1, 10)0.9914 (2, 10)**7 (3, 12)0.306**3 (2, 8)**2 (1, 10)0.470**Condom use since recognized a need to seek care0.417**0.5620.369** Every time19.8%27.5%28.5%**33.3%**15.0%**22.7%** Most times8.0%2.5%9.8%**0.0%**7.1%**4.6%** Half of the time8.0%0.0%7.3%**0.0%**8.4%**0.0%** Sometimes10.6%25.0%10.6%**16.7%**10.6%**31.8%** Not at all53.6%45.0%43.9%**50.0%**58.9%**40.9%**[^1][^2][^3][^4][^5]

GU medicine respondents were also more likely than GP-LESSH respondents to report *new* partner(s) since recognizing a need to seek care: 44.7% versus 33.3%, with again, a more marked difference among men (42.7% versus 27.8%) than women (45.7% versus 38.1%). However, both GU medicine patients and GP-LESSH patients reported a median of four sex acts since recognizing a need to seek care (interquartile range: 2--10). Over three-quarters of these reported *un*protected sex at least once, a proportion that was larger among GU medicine patients than GP-LESSH patients (80.2% versus 72.5%). GU medicine patients were more likely than GP-LESSH patients to report not using condoms at all during this time (53.6% versus 45.0%, respectively).

### Testing for STIs {#s3b7}

In both settings, almost all (94.1%) patients attending for a new episode of care who were attending for a suspected STI (see footnotes to Figure [3](#IJSA-12-055F3){ref-type="fig"}) had a genital examination. Similarly, almost all were tested for at least one of chlamydia, gonorrhoea, syphilis and/or HIV (Figure [3](#IJSA-12-055F3){ref-type="fig"}). This proportion was slightly larger among GP-LESSH patients (94.4% versus 88.4%) but GP-LESSH patients were more likely than GU medicine patients to be new patients rather than attending for a new episode of care or a follow-up appointment. Very few (1.2%) tested just for chlamydia. Indeed, 79.2% of GP-LESSH respondents and 65.5% of GU medicine respondents were recorded as testing for chlamydia, gonorrhoea, syphilis *and* HIV, although gender differences were evident in both settings: 96.3% versus 68.9% for men and women attending GP-LESSH, respectively; 74.4%, versus 59.1% for men and women attending GU medicine, respectively. Figure 3STI tests received by patients attending for a new episode of care (denominator excludes patients reporting attending for a follow-up appointment, leaving: 585 GU medicine patients and 72 GP-LESSH patients, thus numbers of GP-LESSH patients too small to permit analyses by gender) reporting reason(s) suggestive of an STI (among patients reporting 1+ of the following reason(s) for attendance: 'I have (or had) symptoms', 'My partner has (or had) symptoms', 'I did not have symptoms but wanted a check-up', 'My partner has been diagnosed with an infection and needed to come to the clinic/surgery', 'Someone from the clinic/surgery called me in', 'My GP or practice nurse told me to come here') by setting (GU medicine clinic versus GP-LESSH). GU = genitourinary; GP-LESSH = general practice-based Locally Enhanced Services for Sexual Health; STI = sexually transmitted infection; CT = *Chlamydia trachomatis*; GC = gonorrhoea

### STI diagnosis/es {#s3b8}

In both settings, men were more likely to have acute STI diagnosis/es than women (31.3% versus 20.0%, overall). In GU medicine, the most common diagnosis was non-specific urethritis among men (13.4%), and anogenital warts (first episode) among women (8.1% versus 10.6% among men), the latter also the commonest diagnosis in both male and female GP-LESSH patients (18.8% and 13.0%, respectively). Figure [4](#IJSA-12-055F4){ref-type="fig"} shows the percent of patients diagnosed with STIs during their episode of care by setting. Figure 4Percent of patients diagnosed with STIs during their episode of care by setting (GU medicine clinic versus GP-LESSH). Denominator excludes patients who did not consent to linkage of their questionnaire data to an extract of their clinical data, leaving: 766 GU medicine patients and 86 GP-LESSH patients, thus numbers of GP-LESSH patients too small to permit analyses by gender. Corresponding GUMCAD codes are given in parentheses. GU = genitourinary; GP-LESSH = general practice-based Locally Enhanced Services for Sexual Health; STI = sexually transmitted infection; NSU = non-specific urethritis; CT = *Chlamydia trachomatis*; GC = gonorrhoea

In both settings, symptomatic patients were more likely to have acute STI diagnosis/es than patients without or unsure as to whether they had symptoms: 35.9% versus 19.5%, respectively, among GU medicine patients; 28.6% versus 20.0%, respectively, among GP-LESSH patients.

### Management of STI cases in GP-LESSH {#s3b9}

A total of 24 diagnoses were recorded among the 19 GP-LESSH respondents diagnosed with acute STIs. Appropriate treatment was prescribed for 21 of these STIs (Supplementary Table S3), while two had first episode anogenital warts and were referred elsewhere for treatment (GU medicine and dermatology). The other was first episode herpes for which no treatment was documented. Two further GP-LESSH patients without STI diagnoses were referred to general practice.

Six GP-LESSH respondents diagnosed with recurrences of anogenital warts or anogenital herpes (data not shown) were recorded as receiving appropriate treatment from the GP-LESSH. Five cases were recorded as 'epidemiological treatment for suspected chlamydia' and one case of 'epidemiological treatment of suspected non-specific genital infection (NSGI)'. All were appropriately treated in GP-LESSH.

Six cases of chlamydia were diagnosed among the GP-LESSH sample, of which three were recorded as having at least one partner tested. Partner(s) of two of these cases were recorded as having been treated for chlamydia.

DISCUSSION {#s4}
==========

Statement of principal findings {#s4a}
-------------------------------

The GP-LESSH patients surveyed took longer both to seek *and* to receive care. This may be due in part to the service being open just once a week, and also lower perceived risk by GP-LESSH patients and/or service staff since a smaller proportion of GP-LESSH patients reported symptoms and some sexual risk behaviours. There was no difference by setting in either the proportion of patients reporting previous STI diagnosis/es or having acute STI diagnoses. Almost all GP-LESSH respondents received a genital examination, three-quarters received comprehensive STI testing, and almost all STI cases seen in GP-LESSH were appropriately managed there.

Relation to wider literature {#s4b}
----------------------------

Our finding of lower risk behaviours among GP-LESSH patients is consistent with national probability survey data comparing women reporting chlamydia diagnoses by place of diagnosis.^[@IJSA-12-055C19]^ Our data also suggest that GU medicine and GP-LESSH may serve people with different needs. For example, men attending GP-LESSH were younger than men attending GU medicine, and less likely to have previously sought sexual health care from a GP-LESSH. This suggests that GP-LESSH may be attractive to such men, challenging previous UK data that suggest that men prefer not to access sexual health care from general practice, although these earlier data refer to different areas of the UK and not specifically to GP-LESSH.^[@IJSA-12-055C20]^ However, at the time of our survey, there was no GU medicine clinic in two of the locations with a GP-LESHH, and local data suggest that geographical access is more important to patients than timely access.^[@IJSA-12-055C21]^

In contrast with previous studies of STI management in unselected general practices,^[@IJSA-12-055C16],[@IJSA-12-055C22],[@IJSA-12-055C23]^ we found that patients with suspected STIs received comprehensive investigation in Cornwall\'s GP-LESSH, and those who had STIs diagnosed in this setting were appropriately managed. It should be noted that the general practices we sampled were not offering STI care within routine practice, rather sexual health sessions in line with an agreed service specification. Other research has shown substantial variation in the delivery of LESSH,^[@IJSA-12-055C11]^ so it cannot be assumed that all GP-LESSH have similar outcomes to those we studied.

Strengths and weaknesses of the study {#s4c}
-------------------------------------

Due to convenience sampling our data are not fully representative of the target populations. By focusing on one geographical area of the UK, we also limit the extent to which our results can be generalized. We had planned to compare GU medicine and GP-LESSH in other areas but this was not feasible: in one area because the establishment of a GP-LESSH had been postponed, and for logistical reasons related to the LESSH configuration in another area.^[@IJSA-12-055C11],[@IJSA-12-055C12]^

Despite reasonable response rates, our sample of GP-LESSH patients was much smaller than that of GU medicine patients. This reflects the much smaller scale of GP-LESSH services than GU medicine clinics (with on average just 7 patients seen per week per practice over the study period, by contrast with an average of 152 patients per week at the main GU medicine clinic in Cornwall^[@IJSA-12-055C15]^) as well as the greater difficulty of recruiting geographically dispersed GP-LESSH services.^[@IJSA-12-055C24]^

While we lacked statistical power to detect some differences, given the current dearth of data on people attending community-based services for sexual health care, we believe that it is important that our data and reproducible methods are disseminated,^[@IJSA-12-055C17]^ so service planners and providers can improve their understanding of the risk profiles, and thus needs, of people attending different types of service in their locality.

Meaning of the study: possible mechanisms and implications for clinicians and policy-makers {#s4d}
-------------------------------------------------------------------------------------------

While symptomatic patients in both settings were more likely to have acute STIs diagnosed, a substantial minority of asymptomatic patients were also diagnosed with STIs. Risk assessment and triage strategies that differentiate patients according to the presence/absence of reported symptoms are therefore inappropriate and ill-advised, as others have suggested.^[@IJSA-12-055C25]^ Similarly, while GP-LESSH patients may be less likely to present with symptoms, it should not be assumed that they only require minimal testing, as overall, GP-LESSH patients were just as likely to have acute STIs as GU medicine patients.

While the proportion of men who identified as MSM in GP-LESSH was smaller than in the GU medicine sample, 5.0% is still substantially higher than in the general population.^[@IJSA-12-055C26]^. Furthermore, only four of the six MSM who attended the GP-LESSH studied were recorded as having tested for all of chlamydia, gonorrhoea, syphilis and HIV. We do not have data on whether throat or rectal sampling was done. Our data support the need to offer a full range of services for the highest risk in all settings, or prompt referral where that is not possible, as high-risk individuals do access LESSH. For example, provision of a full range of essential services for MSM, including HIV, syphilis and lymphogranuloma venereum testing and hepatitis B vaccination, needs to be available either on site or through proactive referral.

Variations in demography and geography mean that different localities require different combinations of specialist GU medicine and community-based STI services, which may include different models of primary-care delivered sexual health services.^[@IJSA-12-055C27]^ Our data suggest that the model of GP-LESSH we studied may be helping to meet the needs of patients in Cornwall and assisting in the delivery of the National Strategy,^[@IJSA-12-055C1]^ providing a service beyond that of basic STI care. However, it is also important to recognize that where STI services are not open daily, protocols need to be in place to ensure that people who try to use them are, as a minimum, signposted to service(s) where they can receive appropriate care; informed of the need to seek urgent care; and advised to abstain from sex while they do so. These recommendations apply regardless of setting. Any measure that facilitates prompt access to curative treatment, for example, service-led initiatives that enable patients to receive fast referral to this care, can only increase public health benefit. This illustrates the importance of collaboration in the protocols and operation of local STI services.

Unanswered questions and future research {#s4e}
----------------------------------------

As community services expand, it is crucial that they offer comprehensive STI care to their patients. STI service planners must ensure that they understand and monitor their patient population, and more generally, their local population to ensure that their transmission prevention needs are met by local STI services. Failing to meet these needs has the inevitable public health consequence of increased, avoidable STI transmission.^[@IJSA-12-055C28]^
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Supplementary Table S1A comparison of patients' demographics, sexual behaviours, and health-related characteristics by setting (GU medicine versus GP-LESSH) and genderGenderMales and femalesMalesFemalesSettingGU medicineGP-LESSH*P* value\*GU medicineGP-LESSH*P* value\*GU medicineGP-LESSH*P* value\**P* value for gender difference within*Denominator9331113974353668*CharacteristicGU medicineGP-LESSH**Demographic** Age0.4940.2180.6420.0010.552  \<2020.5%20.7%10.9%20.9%27.6%20.6%  20--2430.6%36.0%30.0%34.9%31.1%36.8%  25--2916.5%19.8%18.3%18.6%15.2%20.6%  30--348.7%8.1%12.9%14.0%5.6%4.4%  35--398.0%3.6%9.1%2.3%7.1%4.4%  40--445.1%5.4%4.6%4.7%5.4%5.9%  45+10.6%6.3%14.2%4.7%7.9%7.4%  Median (lower, upper quartiles)24 (20, 34)23 (23, 29)27 (22, 36)24 (20, 30)23 (19, 30)23 (20, 29) White ethnicity99.6%96.4%0.04599.8%95.4%0.03799.4%97.1%0.0570.1610.697**Sexual behavioural** Gender of partner(s), past year0.4600.6850.306\<0.0010.451  Only opposite-sex partner(s)94.1%94.1%89.8%95.0%97.1%93.6%  Only same-sex partner(s)4.0%2.9%8.5%5.0%0.8%1.6%  Both opposite- and same-sex partners1.9%2.9%1.7%0.0%2.0%4.8% Number of partners, past year0.1530.6410.7520.0230.269  136.1%40.2%31.0%35.7%39.7%43.1%  221.7%19.6%17.9%16.7%24.3%21.5%  3--420.4%23.4%20.1%26.2%20.7%21.5%  5--916.5%15.9%20.9%21.4%13.4%12.3%  10+5.4%0.9%10.2%0.0%1.9%1.5%  Median (lower, upper quartiles)2 (1, 4)2 (1, 3)3 (1, 5)2 (1, 4)2 (1, 3)2 (1, 3) Number of *new* partners, past year0.1320.2650.1330.1470.685  019.2%26.7%18.2%23.8%19.9%28.6%  130.0%27.6%26.0%31.0%32.8%25.4%  2+50.8%45.7%55.8%45.2%47.3%46.0%  Median (lower, upper quartiles)2 (1, 3)1 (0, 3)2 (1, 4)1 (1, 3)1 (1, 2)1 (0, 3) Number of partners, past 3 months0.2590.0070.3520.0240.381  09.4%12.8%9.5%9.5%9.3%14.9%  161.3%64.2%54.1%71.4%66.5%59.7%  2+29.3%22.9%36.4%19.1%24.2%25.4%  Median (lower, upper quartiles)1 (1, 2)1 (1, 1)1 (1, 2)1 (1, 1)1 (1, 1)1 (1, 2)**Health-related** Attended service before0.1620.1550.4580.1080.345  No^†^43.4%55.5%46.0%67.4%41.6%47.8%  Yes for a different episode of care44.4%32.7%40.8%20.9%47.1%40.3%  Yes for the same episode of care12.1%11.8%13.2%11.6%11.4%11.9% Registered with a GP0.2230.0180.4370.0040.095  No3.2%5.5%5.6%9.5%1.6%2.9%  Yes92.9%87.3%89.0%73.8%95.7%95.6%  I\'m not sure3.8%7.3%5.4%16.7%2.8%1.5% Ever tested for chlamydia0.3500.6900.0030.070  No20.3%21.1%28.2%35.7%0.28814.7%11.9%  Yes75.1%77.1%65.6%59.5%81.8%88.1%  Not sure4.6%1.8%6.2%4.8%3.5%0.0% Previous STI diagnosis/es0.6630.7340.9110.1970.549  No59.8%63.9%61.2%71.4%58.7%59.1%  Yes35.5%34.3%33.0%28.6%37.3%37.9%  Not sure4.7%1.9%5.9%0.0%3.9%3.0%[^6][^7][^8] Supplementary Table S2A comparison of reasons reported for seeking care by setting (GU medicine versus GP-LESSH) and genderGenderMales and femalesMalesFemalesSettingGU medicineGP-LESSH*P* value\*GU medicineGP-LESSH*P* value\*GU medicineGP-LESSH*P* value\**Denominator9331113974353668*Reasons for seeking care^†^I have (or had) symptoms38.9%34.0%0.40636.2%29.3%0.13840.9%37.1%0.624My partner has (or had) symptoms7.9%4.9%0.10511.2%4.9%0.2745.4%4.8%0.776I did not have symptoms but wanted a check-up^‡^36.3%47.6%0.35536.2%48.8%0.24436.4%46.8%0.434My partner has been diagnosed with an infection and needed to come to the clinic/surgery4.9%4.9%0.9955.5%4.9%0.7774.4%4.8%0.788Someone from the clinic/surgery called me in1.2%0.0%0.6901.4%0.0%0.6991.0%0.0%0.712I wanted a HIV test7.1%4.9%0.4118.7%0.0%0.6215.8%8.1%0.476My GP or practice nurse told me to come here13.0%10.7%0.77410.6%7.3%0.49514.7%12.9%0.860My symptoms have not gone away since I last came here for treatment5.2%5.8%0.6786.3%4.9%0.7444.4%6.5%0.084Last time I came here someone asked me to come back for more treatment or for another check-up /test6.8%4.9%0.7534.6%7.3%0.6968.5%3.2%0.353Other reason(s)4.9%1.9%0.0203.3%0.0%0.6986.0%3.2%0.099[^9][^10][^11][^12] Supplementary Table S3Treatment prescribed/care recorded for GP-LESSH patients diagnosed with acute STIs\*Study numberSTI or epidemiological treatment recordedTreatment/care recordedManagement regarded as appropriate?3010Anogenital warts, first attack\
Epi treatment of suspected NSGIAzithromycin stat 1 g\
Warticon 4 weeks -- reviewAppropriate treatment3021Chlamydial infection\
Anogenital warts first attack\
Epi treatment of suspected CTAzithromycin stat 1 g\
Warticon 4Appropriate treatment3022Chlamydial infectionAzithromycin stat 1 gAppropriate treatment3034Anogenital warts, first attackWarticonAppropriate treatment3038Non-GU/NSU/treatment of mucopurulent cervicitis in females\
Anogenital warts, first attackReferred to GU medicineReferral for care3049Anogenital warts, first attackNone recordedNo treatment recorded3102Anogenital HSV, first attackAciclovir 5 daysAppropriate treatment3105Chlamydial infectionDoxycycline 100 mg twice daily 2 weeks\
Metronidazole 400 mg twice daily 1 weekAppropriate treatment3112Chlamydial infectionZithromax 1 g 1 dayAppropriate treatment3115Anogenital warts, first attackCryotherapyAppropriate treatment3117Chlamydial infection\
PIDDoxycycline 2 weeks\
Metronidazole 1 weekAppropriate treatment3203Anogenital warts, first attackCryotherapyAppropriate treatment3215Anogenital warts, first attackCryotherapyAppropriate treatment3219Chlamydial infectionAzithromycinAppropriate treatment3221Anogenital HSV, first attack\
Epi treatment of suspected CTAzithromycinUnclear for HSV; appropriate treatment for CT3224Anogenital warts, first attack\
Epi treatment of suspected CTAzithromycin\
CryotherapyAppropriate treatment3229Anogenital warts, first attackWarticon\
Metronidazole gelAppropriate treatment\
Unclear -- possible treatment for BV3230Anogenital warts, first attackWarticon\
Referral to dermatologyAppropriate treatment and referral for care3231Anogenital warts, first attackWarticonAppropriate treatment[^13][^14]

[^1]: GU = genitourinary; GP-LESSH = general practice-based Locally Enhanced Services for Sexual Health

[^2]: \**P* value for difference between settings

[^3]: ^†^Among all patients

[^4]: ^‡^Among patients reporting sex since recognizing a need to seek care

[^5]: ^§^Estimates are shown in bold to denote that caution is needed with their interpretation due to small denominators

[^6]: GU = genitourinary; GP-LESSH = general practice-based Locally Enhanced Services for Sexual Health; STI = sexually transmitted infection

[^7]: \**P* value for difference between settings

[^8]: ^†^'No' corresponds to those patients who had never attended the GP surgery before and those patients who had attended the GP surgery but not for a sexual health reason

[^9]: GU = genitourinary; GP-LESSH = general practice-based Locally Enhanced Services for Sexual Health

[^10]: \**P* value for difference between settings

[^11]: ^†^Patients could report more than one reason for seeking care. Response options were presented in the same order in both questionnaires

[^12]: ^‡^This does not correspond to the proportion of asymptomatic screens carried out because asymptomatic patients sometimes reported other reasons for attendance, e.g. wanting an HIV test

[^13]: GU = genitourinary; GP-LESSH =general practice-based Locally Enhanced Services for Sexual Health; STI = sexually transmitted infection; NSU = non-specific urethritis; HSV = herpes simplex virus; BV = bacterial vaginosis; CT = chlamydia; NSGI = non-specific genital infection

[^14]: \*Only patients with acute STI diagnosis/es are included in this table. One patient was excluded as they had 'Advice re. molluscum' recorded in their notes. Another was recorded as 'for psoriasis -- balanitis' in their notes. A further five patients were recorded as receiving 'epidemiological treatment of suspected CT' -- all of whom received appropriate medication. A further six patients are excluded from this table as they were recorded as having 'anogenital HSV: recurrence' (*n* = 4) or 'anogenital warts: recurrence' (*n* = 2)
